Recombinant Antibody to Interleukin 31 (IL31) Felis catus; Feline (Cat) Protein, Antibody, Assaykit, Service

Add to Cart Distributors
Overview
Properties
  • SourceRecombinant monoclonal antibody preparation, Host Mouse
  • Ig Isotype mouse IgG2b Kappa, Clone Number n/a
  • PurificationProtein A + Protein G affinity chromatography
  • LabelNone
  • Immunogen n/a
  • Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
  • TraitsLiquid, Concentration 1mg/mL
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Recombinant Antibody to Interleukin 31 (IL31) Packages (Simulation)
  • Recombinant Antibody to Interleukin 31 (IL31) Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specifity

The antibody is a mouse monoclonal antibody raised against IL31. It has been selected for its ability to recognize IL31 in immunohistochemical staining and western blotting.

Usage

Western blotting: 0.2-2µg/mL;1:500-5000
Immunohistochemistry: 5-20µg/mL;1:50-200
Immunocytochemistry: 5-20µg/mL;1:50-200
Optimal working dilutions must be determined by end user.

Storage

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Giveaways

Citations

  • Increased serum levels of Interleukin-31 could modulate inflammatory processes in multiple sclerosisSiaic-Review:Source
  • Increased levels of interleukin 31 (IL-31) in osteoporosisPubMed: 2644965
  • Interleukin-31 expression and relation to disease severity in human asthmapmc:PMC4783779
  • Immediate-type allergic and protease-mediated reactions are involved in scratching behaviour induced by topical application of Dermatophagoides farinae extract in NC/Nga mice.pubmed:28191683
  • The transcription factor EPAS1 links DOCK8 deficiency to atopic skin inflammation via IL-31 induction.pubmed:28067314
  • Immediate-type allergic and protease-media ted reactions are involved in scratching behavior induced by topical application of Dermatophagoides farinae extract in NC/Nga micedoi:10.1111
  • アトピー性皮膚炎の痒みの発症機序に関する研究
  • Determination the Role of Interleukin 31 (IL-31) Levels in Three Real Allergic Diseases (Asthma, Rhinitis, Urticaria)

Recommend products